To define the concentration of anti -rubella virus (RV) antibodies discriminating nonimmune from immune persons and to characterize immune responses to rubella vaccination, serologic studies were performed after rubella vaccination in persons with low or undetectable antibody concentrations. Thirty-six subjects with primary immune responses had prevaccination anti-RV IgG concentrations õ15 IU/mL by ELISA and negative results by radial hemolysis. Eighty-three subjects with secondary immune responses had mean IgG increases of 9 IU/mL within 2 weeks. Eight of them had initial IgG levels õ15 IU/mL, and 2 were negative by radial hemolysis. Both groups attained similar antibody levels after 1 -3 months. Secondary immune responses to rubella vaccination were delayed by ú2 weeks and thus resembled the time course of primary immunization, but IgM responses and IgG avidity were distinct between subjects with primary or secondary immune responses. Thresholds for immunity õ15 IU/mL entail the risk of withholding rubella vaccination from susceptible persons.
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Prevention of the congenital rubella syndrome rests on the secondary immune responses [8, 11, 12, 28 -30] . However, rubella revaccination may induce only weak or transient reefficient implementation of childhood vaccination programs and on the detection and vaccination of women of childbearing sponses [11, 21, 22] . The question ''are many women immunized against rubella unnecessarily?'' [12] remains unanage who are susceptible to rubella [1] . Definition of a cutoff level for anti -rubella virus (RV) antibodies that reliably indiswered, particularly for the allegedly more sensitive modern tests. We therefore studied the immune response in persons cates previous exposure and immunization by RV, and thereby presumably immunity in terms of protection from intrauterine who had received rubella vaccine because of low or undetectable anti-RV antibodies, in order to establish the cutoff for an infection, is therefore important [1 -3] . Hemagglutination inhibition and radial hemolysis are time-honored techniques with automated IgG ELISA and to compare its performance with radial hemolysis as well as to characterize the kinetics and disadvantages such as nonspecific inhibition by serum components other than antibodies [4 -6] and difficulties in providing vigor of primary and secondary responses. suitable reagents. They are increasingly being replaced by various ELISAs or latex agglutination assays [1, 7 - [7] . This creates problems for standardization 1995, consecutive testing of 5060 subjects for anti-RV IgG reand uncertainties as to the antibody levels that indicate immuvealed 1015 with low or undetectable levels of IgG (i.e., õ40 IU/ nity [4, 5, 9 -14] . The estimation of the persistence of anti-RV mL). Of these, 501 were offered serologic testing if their physicians antibodies [15 -19] and the surveillance of rubella vaccination considered rubella vaccination to be indicated and if they were strategies by age-stratified seroprevalence studies [20] also denegative for anti-RV IgM. Determination of anti-RV IgG was pend on the reliability of the techniques in detecting susceptible offered at 1 week and 1-2 months after vaccination. We obtained persons in need of vaccination.
information on rubella vaccination and serum samples from a total
The response to vaccination may give insight into the immuof 165 subjects (only 4 were men). Of the subjects, 139 had been nologic experience of a person irrespective of the current serum tested in a pregnancy screening program, 19 were health care level of antibodies [21 -24] . The production of high-avidity workers, and 7 were tested for other reasons. One hundred fortyseven first samples were taken within a mean of 7 days (SD, 2.6) IgG within several days after reexposure to RV [25 -27] and and 119 samples within 37 days (SD, 9) after vaccination. A third the lack of an IgM response are the expected hallmarks of sample was obtained from 11 subjects after 56-545 days. The group without follow-up contained 282 women and 54 men. The median age and anti-RV IgG concentration were similar in vaccinated women before vaccination and in women without follow-up JID 1997; 175 (April) were maintained at 2-8ЊC for 2-10 days, until they were aliquoted a primary immune response to rubella vaccination character- rubella vaccination has a high protective efficacy, in particular between 27 and 150 IU/mL (median, 67 IU/mL). Eleven for viremic infections [1, 2, 22, 28, 34] . However, in the abpersons with prevaccination results §15 IU/mL had slightly sence of wild virus exposure, protective vaccine-induced imlower values than the 6 with negative prevaccination results munity may wane [35, 36] . A few cases of reinfection during (medians, 66 and 74 IU/mL, respectively; P §.48, Mannpregnancy, with transmission of the virus to the fetus and the Whitney U test). This is also reflected in 11 of these 17 emergence of congenital rubella syndrome, have been desubjects who could be grouped according to their immune scribed in women with well-documented immune responses to response ( figures 1A, 3) . vaccine or wild virus before conception [37, 38] . In spite of this, No vaccination side effects were reported.
any level of detectable antibody to RV is generally considered presumptive evidence of protective immunity [1 -3] , especially with tests that correlate with neutralizing antibodies [39, 40] .
Discussion
Although the presence of anti-RV antibodies detectable at any Antibodies produced after exposure to wild type RV usually level does not completely rule out the possibility of viremic infections by wild type RV and transmission to the fetus [37, confer lifelong protection from reinfection [17, 33] 38], the demonstration of the lack of previous exposure and IgM response [11, 22, 23] . Reinfections by wild type virus, however, have the potential to induce IgM antibodies, but immune response to wild type or attenuated vaccine virus is of preeminent importance. However, standardization of antiusually at low levels [22, 44 -46] . In our study, secondary immune responses to rubella vaccination were unexpectedly RV antibody concentrations for a variety of different techniques is difficult to achieve, particularly at low levels [4, 8, 14] . This characterized by a quantitatively negligible, albeit statistically significant, increase in anti-RV IgG concentrations within 2 may jeopardize the recognition of susceptible persons who need vaccination in order to curtail transmission of RV into and weeks and by peak levels after 1 -3 months that were not significantly higher than those in primary responders. Such within the female population of childbearing age. We approached this problem by studying the immune response to delayed and attenuated secondary antibody responses have previously been described in a few subjects after intranasal rubella vaccination.
The evolution of the avidity of anti-RV IgG and the produc-RV challenge [22, 46] or RV revaccination [21, 24] . As we do not know the immunization history of most of our study tion of specific IgM antibodies within 3 months after rubella vaccination clearly distinguished groups with primary and secparticipants, the potential contribution of the type of primary immunization (by wild type or vaccine virus) to this sluggish ondary immune responses. Primary immune responses evolved as expected, with an IgM response and IgG antibodies of low secondary response remains undefined and will be impossible to ascertain in a population with ongoing wild virus circulaavidity appearing within 4 weeks.
Secondary immune responses to vaccines are expected to tion [47, 48] . The presence of neutralizing antibodies in spite of very low or undetectable antibody levels measured by other show a rapid increase of IgG production [41 -43] techniques [11] may inhibit the replication of vaccine virus After revaccination, rates of adverse reactions (particularly joint-related complaints in females) have been lower than after and thereby delay or abort the secondary immune response [21, 22, 46] by preventing the production of sufficient amounts primary vaccination [53] . We therefore decline to withhold vaccination from potentially susceptible persons and offer of immunogenic material. The inverse relation between the increase of anti-RV IgG concentrations attained within 3 boosting to persons with low antibody levels. By the same token, this approach avoids overestimating vaccine efficacy in months after vaccination and prevaccination values of IgG is in agreement with this interpretation.
population studies for the surveillance of mass vaccination programs. Some persons fail to respond to repeated RV vaccinations [40] , and patients with congenital RV infection may be tolerant A well-calibrated ELISA for the detection of anti-RV IgG has the potential to be as reliable as established techniques to RV epitopes [40, 49 -52] . In addition, antibody responses to vaccination in previously immunized subjects tend to be such as radial hemolysis, which clearly separates susceptible from immune subjects, even at a lower cutoff than the one transient (this study and [11, 21, 22] ). Therefore, boosting previously immunized persons with low anti-RV antibody conrecommended by the manufacturer of RHG. The sequential use of the two tests in case of a negative ELISA could reduce the centrations may be ineffective, and additional vaccine doses after childhood vaccination should mainly be targeted at the number of false-negative results and still provide the ease and rapidity of an automated test for most cases. The results obunimmunized. In contrast, reinfection by wild type RV may overcome the neutralizing capacity of antibodies and induce tained with the automated ELISA used in this study are not necessarily transferable to other assays, even if they are based antibody levels above those attainable by revaccination [28] .
Both a modern automated ELISA and a radial hemolysis on similar test principles. Some recently developed automated ELISAs for the detection and quantitation of anti-RV IgG may test for the determination of rubella immunity had excellent specificity in identifying persons who have previously mounted
give rise to false-positive results in a large proportion of subjects mounting a primary immune response to vaccination, paran immune response to RV. Thus, the cutoffs recommended for these tests avoid false-positive results and ensure that vacciticularly when using a cutoff value below 15 IU/mL (data not shown). Therefore, for low levels of antibodies, the correct nation can be targeted at all susceptible persons, especially if the indication to vaccinate is extended into a safety margin of calibration of every assay should be ascertained using serum panels that have been characterized according to biologic criteweakly positive results (e.g., up to 25 IU/mL). Lowering the cutoff value would compromise specificity, yet it would imria instead of relying exclusively on standard serum preparations. In defining the cutoff values, priority should be given to prove the predictive value of positive results only slightly, as the majority of false-negative results could not be avoided.
the avoidance of false-positive results.
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